Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)
BACKGROUND-: Hypertension treatment guidelines recommend that blood pressure (BP) be lowered to <140/90 mm Hg, but that a reduction to <130/80 mm Hg be adopted in patients at high cardiovascular (CV) risk. We investigated the CV and renal benefits associated with these BP targets in the high-C...
| Published in: | Circulation |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
2011
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-80054959783&doi=10.1161%2fCIRCULATIONAHA.110.008870&partnerID=40&md5=f989306e751fbfbe4334b5f28c48dc69 |